{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T12:13:35Z","timestamp":1791288815133,"version":"4.3.0"},"reference-count":120,"publisher":"MDPI AG","issue":"7","license":[{"start":{"date-parts":[[2015,6,30]],"date-time":"2015-06-30T00:00:00Z","timestamp":1435622400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Toxins"],"abstract":"<jats:p>Pain is a natural protective mechanism and has a warning function signaling imminent or actual tissue damage. Neuropathic pain (NP) results from a dysfunction and derangement in the transmission and signal processing along the nervous system and it is a recognized disease in itself. The prevalence of NP is estimated to be between 6.9% and 10% in the general population. This condition can complicate the recovery from stroke, multiple sclerosis, spinal cord lesions, and several neuropathies promoting persistent disability and poor quality of life. Subjects suffering from NP describe it as burning, itching, lancing, and numbness, but hyperalgesia and allodynia represent the most bothersome symptoms. The management of NP is a clinical challenge and several non-pharmacological and pharmacological interventions have been proposed with variable benefits. Botulinum toxin (BTX) as an adjunct to other interventions can be a useful therapeutic tool for the treatment of disabled people. Although BTX-A is predominantly used to reduce spasticity in a  neuro-rehabilitation setting, it has been used in several painful conditions including disorders characterized by NP. The underlying pharmacological mechanisms that operate in reducing pain are still unclear and include blocking nociceptor transduction, the reduction of neurogenic inflammation by inhibiting neural substances and neurotransmitters, and the prevention of peripheral and central sensitization. Some neurological disorders requiring rehabilitative intervention can show neuropathic pain resistant to common analgesic treatment. This paper addresses the effect of BTX-A in treating NP that complicates frequent disorders of the central and peripheral nervous system such as spinal cord injury, post-stroke shoulder pain, and painful diabetic neuropathy, which are commonly managed in a rehabilitation setting. Furthermore, BTX-A has an effect in relief pain that may characterize less common neurological disorders including post-traumatic neuralgia, phantom limb, and complex regional pain syndrome with focal dystonia. The use of BTX-A could represent a novel therapeutic strategy in caring for neuropathic pain whenever common pharmacological tools have been ineffective. However, large and well-designed clinical trials are needed to recommend BTX-A use in the relief of neuropathic pain.<\/jats:p>","DOI":"10.3390\/toxins7072454","type":"journal-article","created":{"date-parts":[[2015,6,30]],"date-time":"2015-06-30T11:40:13Z","timestamp":1435664413000},"page":"2454-2480","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":52,"title":["Botulinum Toxin Type A for the Treatment of Neuropathic Pain in Neuro-Rehabilitation"],"prefix":"10.3390","volume":"7","author":[{"given":"Domenico","family":"Intiso","sequence":"first","affiliation":[{"name":"Unit of Neuro-rehabilitation, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS)  Casa Sollievo della Sofferenza Hospital, San Giovanni Rotondo (FG) 71013, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Basciani","sequence":"additional","affiliation":[{"name":"Unit of Neuro-rehabilitation, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS)  Casa Sollievo della Sofferenza Hospital, San Giovanni Rotondo (FG) 71013, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1452-8485","authenticated-orcid":false,"given":"Andrea","family":"Santamato","sequence":"additional","affiliation":[{"name":"Department of Physical Medicine and Rehabilitation, OORR Hospital, University of Foggia,  Foggia 71121, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Intiso","sequence":"additional","affiliation":[{"name":"Unit of Neuro-rehabilitation, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS)  Casa Sollievo della Sofferenza Hospital, San Giovanni Rotondo (FG) 71013, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filomena","family":"Di Rienzo","sequence":"additional","affiliation":[{"name":"Unit of Neuro-rehabilitation, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS)  Casa Sollievo della Sofferenza Hospital, San Giovanni Rotondo (FG) 71013, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2015,6,30]]},"reference":[{"key":"ref_1","unstructured":"Merskey, H., and Bogduk, N. (1994). Classification of Chronic Pain, IASP Task Force on Taxonomy, IASP Press. [2nd ed.]."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"63","DOI":"10.2174\/18715273113126660192","article-title":"Future directions in the treatment of neuropathic pain: A review on various therapeutic targets","volume":"13","author":"Gangadhar","year":"2014","journal-title":"CNS Neurol. Disord. Drug Targets"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/j.pain.2013.11.013","article-title":"Neuropathic pain in the general population: A systematic review of epidemiological studies","volume":"155","author":"Austin","year":"2014","journal-title":"Pain"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1136\/practneurol-2013-000536","article-title":"Neuropathic pain: Diagnosis and treatment","volume":"13","author":"Magrinelli","year":"2013","journal-title":"Pract Neurol"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.pain.2005.08.013","article-title":"Algorithm for neuropathic pain treatment: An evidence based proposal","volume":"118","author":"Finnerup","year":"2005","journal-title":"Pain"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1093\/bja\/aen107","article-title":"Neuropathic pain: Emerging treatments","volume":"101","author":"Dray","year":"2008","journal-title":"Br. J. Anaesth."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"802893","DOI":"10.1155\/2012\/802893","article-title":"Therapeutic use of Botulinum toxin in Neuro-rehabilitation","volume":"2012","author":"Intiso","year":"2012","journal-title":"J. Toxicol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"359","DOI":"10.3109\/17482960903264998","article-title":"Botulinum toxin type A for the treatment of sialorrhoea in amyotrophic lateral sclerosis: A clinical and neurophysiological study","volume":"11","author":"Gilio","year":"2010","journal-title":"Amyotroph. Lateral Scler."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1002\/mds.10420","article-title":"Double-blind, placebo-controlled study to evaluate the efficacy and safety of botulinum toxin type A in the treatment of drooling in parkinsonism","volume":"18","author":"Mancini","year":"2003","journal-title":"Mov. Disord."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1111\/j.0012-1622.2008.02010.x","article-title":"Randomized trial of botulinum toxin injections into salivary glands to reduce drooling in children with neurological disorders","volume":"50","author":"Reid","year":"2008","journal-title":"Dev. Med. Child Neurol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1097\/AJP.0b013e31827a72d2","article-title":"Botulinum toxin A in post-herpetic neuralgia: A parallel, randomized, double-blind, single-dose, placebo-controlled trial","volume":"29","author":"Apalla","year":"2013","journal-title":"Clin. J. Pain"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/1129-2377-14-72","article-title":"Therapeutic efficacy and safety of botulinum toxin type A in trigeminal neuralgia: A systematic review","volume":"14","author":"Hu","year":"2013","journal-title":"J. Headache Pain"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1111\/ene.12393","article-title":"Pooled analysis of the safety and tolerability of onabotulinumtoxinA in the treatment of chronic migraine","volume":"21","author":"Diener","year":"2014","journal-title":"Eur. J. Neurol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"129","DOI":"10.2217\/pmt.13.75","article-title":"Botulinum toxin for neuropathic pain and spasticity: An overview","volume":"4","author":"Brown","year":"2014","journal-title":"Pain Manag."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1093\/infdis\/jit449","article-title":"A novel strain of Clostridium botulinum that produces type B and type H botulinum toxins","volume":"209","author":"Barash","year":"2014","journal-title":"J. Infect. Dis."},{"key":"ref_16","unstructured":"Jankovic, J., and Hallet, M. (1994). Therapy with Botulinum Toxin, Marcel Dekker."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1038\/359832a0","article-title":"Tetanus and boulinum \u2013B neurotoxin block neurotransmitter release by a proteolytic cleavage of synapto-brevin","volume":"359","author":"Schiavo","year":"1992","journal-title":"Nature"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1212\/01.WNL.0000163767.99354.C3","article-title":"A new botulinum toxin type A free of complexing proteins for treatment of cervical dystonia","volume":"64","author":"Benecke","year":"2005","journal-title":"Neurology"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/j.1468-1331.2009.02877.x","article-title":"Routine use of Xeomin in patients previously treated with Botox: Long term results","volume":"16","author":"Dressler","year":"2009","journal-title":"Eur. J. Neurol."},{"key":"ref_20","unstructured":"Merskey, H., and Bogduk, N. (1994). Classification of Chronic Pain: Descriptions of Chronic Pain Syndromes and Definitions of Pain Terms, IASP Press. [2nd ed.]."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.euroneuro.2011.05.005","article-title":"Mechanisms of neuropathic pain","volume":"22","author":"Nickel","year":"2012","journal-title":"Eur. Neuropsychopharmacol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/35093019","article-title":"Molecular mechanisms of nociception","volume":"413","author":"Julius","year":"2001","journal-title":"Nature"},{"key":"ref_23","first-page":"283","article-title":"Neuropathic pain: Role of voltage-dependent calcium channels","volume":"25","author":"Chaplan","year":"2000","journal-title":"Reg. Anesth. Pain Med."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1023\/A:1007090105840","article-title":"Structural basis of sympathetic-sensory coupling in rat and human dorsal root ganglia following peripheral nerve injury","volume":"28","author":"Shinder","year":"1999","journal-title":"J. Neurocytol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/0304-3959(94)00133-Y","article-title":"Reflex sympathetic dystrophy: Evolution of microcirculatory disturbances in time","volume":"60","author":"Kurvers","year":"1995","journal-title":"Pain"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/S0304-3959(00)00286-4","article-title":"Experimental tissue acidosis leads to increased pain in complex regional pain syndrome (CRPS)","volume":"87","author":"Birklein","year":"2000","journal-title":"Pain"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"f7656","DOI":"10.1136\/bmj.f7656","article-title":"Neuropathic pain: Mechanisms and their clinical implications","volume":"348","author":"Cohen","year":"2014","journal-title":"BMJ"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"400","DOI":"10.3109\/00016489309135834","article-title":"Botulinum A toxin effects on rat jaw muscle spindles","volume":"113","author":"Filippi","year":"1993","journal-title":"Acta Otolaryngol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1002\/mds.870020402","article-title":"Localized injections of botulinum toxin for the treatment of focal dystonia and hemifacial spasm","volume":"2","author":"Brin","year":"1987","journal-title":"Mov. Disord."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"S125","DOI":"10.1097\/00002508-200211001-00003","article-title":"Possible mechanisms for the effects of botulinum toxin on pain","volume":"18","author":"Arezzo","year":"2002","journal-title":"Clin. J. Pain"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"I1","DOI":"10.1007\/s00415-004-1102-z","article-title":"Neurobiological basis for the use of botulinum toxin in pain therapy","volume":"251","author":"Mense","year":"2004","journal-title":"J. Neurol."},{"key":"ref_32","first-page":"A474","article-title":"Different doses of botulinum toxin A and pain responsiveness in cervical dystonia","volume":"58","author":"Relja","year":"2002","journal-title":"Neurology"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1757-1146-7-9","article-title":"Efficacy of intraarticular botulinum toxin A and intraarticular hyaluronate plus rehabilitation exercise in patients with unilateral ankle osteoarthritis: A randomized controlled trial","volume":"7","author":"Sun","year":"2014","journal-title":"J. Foot Ankle Res."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"2377","DOI":"10.3899\/jrheum.100336","article-title":"Intraarticular botulinum toxin a for refractory painful total knee arthroplasty: A randomized controlled trial","volume":"37","author":"Singh","year":"2010","journal-title":"J. Rheumatol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"255","DOI":"10.2106\/JBJS.F.00401","article-title":"Treatment of chronic radial epicondylitis with botulinum toxin A. A double-blind, placebo controlled, randomized multicenter study","volume":"89","author":"Placzek","year":"2007","journal-title":"J Bone Joint Surg. Am."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.semarthrit.2011.12.004","article-title":"Injection of botulinum toxin for treatment of chronic lateral epicondylitis","volume":"41","author":"Lin","year":"2012","journal-title":"Semin. Arthritis Rheum."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1097\/AJP.0b013e31823ae65a","article-title":"Is botulinum toxin A effective for the treatment of plantar fasciitis?","volume":"28","author":"Peterlein","year":"2012","journal-title":"Clin. J. Pain."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1177\/0269215512469217","article-title":"Botulinum toxin type A in chronic plantar fasciitis: Clinical effects one year after injection","volume":"27","year":"2013","journal-title":"Clin. Rehabil."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1007\/s11916-013-0386-z","article-title":"An update on botulinum toxin A injections of trigger points for myofascial pain","volume":"18","author":"Zhou","year":"2014","journal-title":"Curr. Pain Headache Rep."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1592\/phco.27.5.657","article-title":"Low-dose botulinum toxin type A for the treatment of refractory piriformis syndrome","volume":"27","author":"Yoon","year":"2007","journal-title":"Pharmacotherapy"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1212\/01.wnl.0000336535.27773.c0","article-title":"Practice parameters and technology assessments: What they are, what they are not, and why you should care","volume":"71","author":"Gronseth","year":"2008","journal-title":"Neurology"},{"key":"ref_42","first-page":"CD007533","article-title":"Botulinum toxin for myofascialpain syndromes in adults","volume":"7","author":"Soares","year":"2014","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1111\/j.1526-4637.2011.01245.x","article-title":"Treatment of refractory pain with botulinum toxins-an evidence-based review","volume":"12","author":"Jabbari","year":"2011","journal-title":"Pain Med."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1002\/ana.24122","article-title":"Botulinum toxin-A treatment reduces human mechanical pain sensitivity and mechanotransduction","volume":"75","author":"Paterson","year":"2014","journal-title":"Ann. Neurol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.coph.2011.11.001","article-title":"Neurotherapeutics to inhibit exocytosis from sensory neurons for the control of chronic pain","volume":"12","author":"Dolly","year":"2012","journal-title":"Curr. Opin. Pharmacol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/j.1526-4610.2004.04007.x","article-title":"Regulation of calcitonin generelated peptide secretion from trigeminal nerve cells by botulinum toxin type A: Implications for migraine therapy","volume":"44","author":"Durham","year":"2004","journal-title":"Headache"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.neuro.2005.01.017","article-title":"Review of a proposed mechanism for the antinociceptive action of botulinum toxin type A","volume":"26","author":"Aoki","year":"2005","journal-title":"Neurotoxicology"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"S28","DOI":"10.1016\/j.parkreldis.2011.06.013","article-title":"Update on antinociceptive mechanism hypothesis of botulinum toxin A","volume":"17","author":"Aoki","year":"2011","journal-title":"J. Parkinsonism Relat. Disord."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.neuroscience.2011.04.026","article-title":"Behavioral and immunohistochemical evidence for central antinociceptive activity of botulinum toxin A","volume":"186","author":"Matak","year":"2011","journal-title":"Neuroscience"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.neuint.2012.05.001","article-title":"Botulinum toxin's axonal transport from periphery to the spinal cord","volume":"61","author":"Matak","year":"2012","journal-title":"Neurochem. Int."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.neuropharm.2013.02.011","article-title":"Involvement of \u03bc-opioid receptors in antinociceptive action of botulinum toxin type A","volume":"70","author":"Drinovac","year":"2013","journal-title":"Neuropharmacology"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.pneurobio.2014.06.001","article-title":"Botulinum toxin A, brain and pain","volume":"119\u2013120","author":"Matak","year":"2014","journal-title":"Prog. Neurobiol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"13","DOI":"10.2340\/16501977-0303","article-title":"European consensus table on the use of botulinum toxin type A in adult spasticity","volume":"41","author":"Wissel","year":"2009","journal-title":"J. Rehabil. Med."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/S1090-3801(02)00055-1","article-title":"Poststroke shoulder pain: A prospective study of the association and risk factors in 152 patients from a consecutive cohort of 205 patients presenting with stroke","volume":"6","author":"Gamble","year":"2002","journal-title":"EJP"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1161\/01.STR.0000254598.16739.4e","article-title":"Shoulder pain after stroke: A prospective population-based study","volume":"38","author":"Lindgren","year":"2007","journal-title":"Stroke"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.pain.2012.10.026","article-title":"Hemiplegic shoulder pain: Evidence of a neuropathic origin","volume":"154","author":"Zeilig","year":"2013","journal-title":"Pain"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1177\/0269215506072082","article-title":"A randomized controlled study of botulinum toxin A in the treatment of hemiplegic shoulder pain associated with spasticity","volume":"21","author":"Kong","year":"2007","journal-title":"Clin. Rehabil."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"440","DOI":"10.2340\/16501977-0066","article-title":"Is botulinum toxin type A effective in the treatment of spastic shoulder pain in patients after stroke? A double-blind randomized clinical trial","volume":"39","author":"Marco","year":"2007","journal-title":"J. Rehabil. Med."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1136\/jnnp.2006.103341","article-title":"Treatment of shoulder pain in spastic hemiplegia by reducing spasticity of the subscapular muscle: A randomized, double blind, placebo controlled study of botulinum toxin A","volume":"78","author":"Yelnik","year":"2007","journal-title":"J. Neurol. Neurosurg. Psychiatr."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1161\/STROKEAHA.107.484048","article-title":"Intramuscular botulinum toxin-A reduces hemiplegic shoulder pain: A randomized, double-blind, comparative study versus intraarticular triamcinolone acetonide","volume":"39","author":"Lim","year":"2008","journal-title":"Stroke"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1136\/jnnp.2007.128371","article-title":"Shoulder pain and external rotation in spastic hemiplegia do not improve by injection of botulinum toxin A into the subscapular muscle","volume":"79","author":"Arwert","year":"2008","journal-title":"J. Neurol. Neurosurg. Psychiatr."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1097\/PHM.0b013e31826ecb02","article-title":"Does Botulinum Toxin Type A Decrease Pain and Lessen Disability in Hemiplegic Survivors of Stroke with Shoulder Pain and Spasticity? A Randomized, Double-Blind, Placebo-Controlled Trial","volume":"91","author":"Marciniak","year":"2012","journal-title":"Am. J. Phys. Med. Rehabil."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1016\/j.apmr.2011.01.015","article-title":"Efficacy of intra-articular injection of botulinum toxin type A in refractory hemiplegic shoulder pain","volume":"92","author":"Castiglione","year":"2011","journal-title":"Arch. Phys. Med. Rehabil."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"409","DOI":"10.3899\/jrheum.101081","article-title":"Botulinum toxin for shoulder pain: A cochrane systematic review","volume":"38","author":"Singh","year":"2011","journal-title":"J. Rheumatol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1038\/sc.2012.2","article-title":"International Spinal Cord Injury Pain (ISCIP) Classification: Part 2. Initial validation using vignettes","volume":"50","author":"Bryce","year":"2012","journal-title":"Spinal Cord"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1038\/sj.sc.3101116","article-title":"Pain following spinal cord injury","volume":"39","author":"Siddall","year":"2001","journal-title":"Spinal Cord"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1097\/AJP.0b013e31804463e5","article-title":"Spinal cord injury pain: The influence of psychologic factors and impact on quality of life","volume":"23","author":"Wollaars","year":"2007","journal-title":"Clin. J. Pain"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1046\/j.1526-4637.2003.03013.x","article-title":"Botulinum toxin a improved burning pain and allodynia in two patients with spinal cord pathology","volume":"4","author":"Jabbari","year":"2003","journal-title":"Pain Med."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1038\/sc.2014.43","article-title":"Effect of subcutaneous injection of botulinum toxin A on spinal cord injury-associated neuropathic pain","volume":"52","author":"Han","year":"2014","journal-title":"Spinal Cord"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.2340\/16501977-0460","article-title":"Botulinum toxin type A in the healing of a chronic buttock ulcer in a patient with spastic paraplegia after spinal cord injury","volume":"41","author":"Intiso","year":"2009","journal-title":"J. Rehabil. Med."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.diabres.2012.11.006","article-title":"By the numbers: New estimates from the IDF Diabetes Atlas Update for 2012","volume":"98","author":"Guariguata","year":"2012","journal-title":"Diabetes Res. Clin. Pract."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1212\/WNL.0b013e3182166ebe","article-title":"Evidence-based guideline: Treatment of painful diabetic neuropathy: Report of the American Academy of Neurology, the American Association of Neuromuscular and Electrodiagnostic Medicine, and the American Academy of Physical Medicine and Rehabilitation","volume":"76","author":"Bril","year":"2011","journal-title":"Neurology"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1111\/j.1464-5491.2008.02397.x","article-title":"Prevalence and risk factors for diabetic neuropathy in an urban south Indian population: The Chennai Urban Rural Epidemiology Study (CURES-55)","volume":"25","author":"Pradeepa","year":"2008","journal-title":"Diabet. Med."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.pcd.2007.07.006","article-title":"Diagnosis of diabetic peripheral neuropathy among patients with type 1 and type 2 diabetes in France, Italy, Spain, and the United Kingdom","volume":"1","author":"Rubino","year":"2007","journal-title":"Prim. Care Diabetes"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"836","DOI":"10.2337\/diacare.20.5.836","article-title":"A multicenter study on the prevalence of diabetic neuropathy in Italy. Italian Diabetic Neuropathy Committee","volume":"20","author":"Fedele","year":"1997","journal-title":"Diabetes Care"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1111\/jdi.12223","article-title":"Prevalence and risk factors of development of peripheral diabetic neuropathy in type 2 diabetes mellitus in a tertiary care setting","volume":"5","author":"Bansal","year":"2014","journal-title":"J. Diabetes Investig."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"2220","DOI":"10.2337\/dc11-1108","article-title":"Prevalence and characteristics of painful diabetic neuropathy in a large community-based diabetic population in the U.K","volume":"34","author":"Abbott","year":"2011","journal-title":"Diabetes Care"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.pmrj.2013.11.007","article-title":"Comparison of balance ability between patients with type 2 diabetes and with and without peripheral neuropathy","volume":"6","author":"Lim","year":"2014","journal-title":"PMR"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.gaitpost.2012.09.024","article-title":"The role of foot morphology on foot function in diabetic subjects with or without neuropathy","volume":"37","author":"Guiotto","year":"2013","journal-title":"Gait Posture"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.jdiacomp.2013.08.007","article-title":"Diabetes, peripheral neuropathy, and lower-extremity function","volume":"28","author":"Chiles","year":"2014","journal-title":"J. Diabetes Complicat."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/j.clinbiomech.2013.06.008","article-title":"Comparison of foot segmental mobility and coupling during gait between patients with diabetes mellitus with and without neuropathy and adults without diabetes","volume":"28","author":"Deschamps","year":"2013","journal-title":"Clin. Biomech. (Bristol Avon)."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.diabet.2008.11.004","article-title":"Prevalence and impact on quality of life of peripheral neuropathy with or without neuropathic pain in type 1 and type 2 diabetic patients attending hospital outpatients clinics","volume":"35","author":"Bouhassira","year":"2009","journal-title":"Diabetes Metab."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"79","DOI":"10.2147\/DMSO.S37415","article-title":"Burden of illness associated with painful diabetic peripheral neuropathy among adults seeking treatment in the US: Results from a retrospective chart review and cross-sectional survey","volume":"6","author":"Sadosky","year":"2013","journal-title":"Diabetes Metab. Syndr. Obes."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1186\/1471-2474-15-137","article-title":"Effects of strengthening, stretching and functional training on foot function in patients with diabetic neuropathy: Results of a randomized controlled trial","volume":"15","author":"Sartor","year":"2014","journal-title":"BMC Musculoskelet. Disord."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/j.jdiacomp.2014.04.007","article-title":"Exercise improves gait, reaction time and postural stability in older adults with type 2 diabetes and neuropathy","volume":"28","author":"Morrison","year":"2014","journal-title":"J. Diabetes Complicat."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.jmpt.2013.09.007","article-title":"Multimodal treatment of distal sensorimotor polyneuropathy in diabetic patients: A randomized clinical trial","volume":"37","author":"Taveggia","year":"2014","journal-title":"J. Manip. Physiol. Ther."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"639","DOI":"10.7326\/M14-0511","article-title":"Pharmacologic interventions for painful diabetic neuropathy: An umbrella systematic review and comparative effectiveness network meta-analysis","volume":"161","author":"Griebeler","year":"2014","journal-title":"Ann. Intern. Med."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1177\/0309364614542266","article-title":"Treatment of painful diabetic peripheral neuropathy","volume":"39","author":"Rosebenrg","year":"2015","journal-title":"Prosthet. Orthot. Int."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1177\/2040622314552071","article-title":"Treatment of painful diabetic neuropathy","volume":"6","author":"Javed","year":"2015","journal-title":"Ther. Adv. Chronic Dis."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.pain.2007.08.033","article-title":"Pharmacologic management of neuropathic pain: Evidence-based recommendations","volume":"132","author":"Dworkin","year":"2007","journal-title":"Pain"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"S52","DOI":"10.1002\/dmrr.817","article-title":"Painful diabetic neuropathy: Treatment and future aspects","volume":"24","author":"Ziegler","year":"2008","journal-title":"Diabetes Metab. Res. Rev."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.ejphar.2010.01.020","article-title":"Botulinum toxin type A reduces pain supersensitivity in experimental diabetic neuropathy: Bilateral effect after unilateral injection","volume":"633","year":"2010","journal-title":"Eur. J. Pharmacol."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1212\/01.wnl.0000345968.05959.cf","article-title":"Botulinum toxin for diabetic neuropathic pain: A randomized double-blind crossover trial","volume":"72","author":"Yuan","year":"2009","journal-title":"Neurology"},{"key":"ref_94","first-page":"106","article-title":"The effects of intradermal botulinum toxin type a injections on pain symptoms of patients with diabetic neuropathy","volume":"19","author":"Ghasemi","year":"2014","journal-title":"J. Res. Med. Sci."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1002\/ana.21427","article-title":"Botulinum toxin type A induces direct analgesic effects in chronic neuropathic pain","volume":"64","author":"Ranoux","year":"2008","journal-title":"Ann. Neurol."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1097\/01.mlg.0000217797.05523.75","article-title":"Botulinum toxin A for neuropathic pain after neck dissection: A dose-finding study","volume":"116","author":"Wittekindt","year":"2006","journal-title":"Laryngoscope"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1080\/16501970410029771","article-title":"Does botulinum toxin A make prosthesis use easier for amputees?","volume":"36","author":"Kern","year":"2004","journal-title":"J. Rehabil. Med."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1016\/j.jpainsymman.2003.09.003","article-title":"Botulinum toxin type A influences stump pain after limb amputations","volume":"26","author":"Kern","year":"2003","journal-title":"J. Pain Symptom Manag."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1212\/WNL.56.12.1762","article-title":"Clinical aspects of multifocal or generalized tonic dystonia in reflex sympathetic dystrophy","volume":"56","author":"Vein","year":"2001","journal-title":"Neurology"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1038\/nrn1991","article-title":"Phantom limb pain: A case of maladaptive CNS plasticity?","volume":"7","author":"Flor","year":"2006","journal-title":"Nat. Rev. Neurosci."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/j.jpain.2009.06.012","article-title":"Central sensitization: A generator of pain hypersensitivity by central neural plasticity","volume":"10","author":"Latremoliere","year":"2009","journal-title":"J. Pain"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/0166-2236(90)90179-E","article-title":"Phantom limbs and the concept of a neuromatrix","volume":"13","author":"Melzack","year":"1990","journal-title":"Trends Neurosci."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0891-8422(23)00657-2","article-title":"Phantom limb pain. Mechanism based management","volume":"11","author":"Sherman","year":"1994","journal-title":"Clin. Podiatr. Med. Surg."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1111\/pme.12283","article-title":"Phantom limb pain: A systematic neuroanatomical-based review of pharmacologic treatment","volume":"15","author":"McCormick","year":"2014","journal-title":"Pain Med."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1111\/j.1526-4637.2008.00554.x","article-title":"Treatment of phantom limb pain with botulinum toxin type A","volume":"10","author":"Jin","year":"2009","journal-title":"Pain Med."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1097\/AJP.0b013e3182264fe9","article-title":"A prospective randomized double-blinded pilot study to examine the effect of botulinum toxin type A injection versus Lidocaine\/Depomedrol injection on residual and phantom limb pain: Initial report","volume":"28","author":"Wu","year":"2012","journal-title":"Clin. J. Pain"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/S1474-4422(11)70106-5","article-title":"Clinical features and pathophysiology of complex regional pain syndrome","volume":"10","author":"Marinus","year":"2011","journal-title":"Lancet Neurol."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1002\/ana.21830","article-title":"Dystonia in complex regional pain syndrome type I","volume":"67","author":"Lang","year":"2010","journal-title":"Ann. Neurol."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1007\/s00415-009-5426-6","article-title":"Systematic mutation analysis of seven dystonia genes in complex regional pain syndrome with fixed dystonia","volume":"257","author":"Gosso","year":"2010","journal-title":"J. Neurol."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/j.jpain.2012.05.003","article-title":"Genetic HLA associations in complex regional pain syndrome with and without dystonia","volume":"13","author":"Roelen","year":"2012","journal-title":"J. Pain"},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1002\/ana.21692","article-title":"Is reflex sympathetic dystrophy\/complex regional pain syndrome type I a small-fiber neuropathy?","volume":"65","author":"Oaklander","year":"2009","journal-title":"Ann. Neurol."},{"key":"ref_112","first-page":"761","article-title":"Responsiveness to botulinum toxin type A in muscles of complex regional pain patients with tonic dystonia","volume":"121","author":"Schilder","year":"2014","journal-title":"J. Neural Transm."},{"key":"ref_113","first-page":"419","article-title":"Intramuscular botulinum toxin in complex regional pain syndrome: Case series and literature review","volume":"14","author":"Kharkar","year":"2011","journal-title":"Pain Physician."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta14260","article-title":"BoTULS investigators (2010). BoTULS: A multicentrerandomized controlled trial to evaluate the clinical effectiveness and cost-effectiveness of treating upper limb spasticity due to stroke with botulinum toxin type A","volume":"14","author":"Shaw","year":"2010","journal-title":"Health Technol. Assess."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1097\/AJP.0b013e31827eafff","article-title":"Subcutaneous and perineural botulinum toxin type A for neuropathic pain: Adescriptive review","volume":"29","author":"Fabregat","year":"2013","journal-title":"Clin. J. Pain"},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"S177","DOI":"10.1097\/00002508-200211001-00010","article-title":"A focused review on the use of botulinum toxins for neuropathic pain","volume":"18","author":"Argoff","year":"2002","journal-title":"Clin. J. Pain"},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1111\/j.1533-2500.2008.00202.x","article-title":"Evidence for the use of botulinum toxin in the chronic pain setting\u2013A review of the literature","volume":"8","author":"Jeynes","year":"2008","journal-title":"Pain Pract."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","article-title":"GRADE: An emerging consensus on rating quality of evidence and strength of recommendations","volume":"336","author":"Guyatt","year":"2008","journal-title":"BMJ"},{"key":"ref_119","unstructured":"McQuay, H.J., Kalso, E., and Moore, R.A. (2008). Systematic Reviews in Pain Research: Methodology Refined, IASP Press."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S1474-4422(14)70251-0","article-title":"Pharmacotherapy for neuropathic pain in adults: A systematic review and meta-analysis","volume":"14","author":"Finnerup","year":"2015","journal-title":"Lancet Neurol."}],"container-title":["Toxins"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6651\/7\/7\/2454\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T20:48:32Z","timestamp":1760215712000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6651\/7\/7\/2454"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6,30]]},"references-count":120,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2015,7]]}},"alternative-id":["toxins7072454"],"URL":"https:\/\/doi.org\/10.3390\/toxins7072454","relation":{},"ISSN":["2072-6651"],"issn-type":[{"value":"2072-6651","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,6,30]]}}}